Source:http://linkedlifedata.com/resource/pubmed/id/11110715
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
13
|
| pubmed:dateCreated |
2000-12-21
|
| pubmed:abstractText |
X-linked sideroblastic anemia (XLSA) is caused by mutations in the erythroid-specific 5-aminolevulinic acid synthase (ALAS2) gene. An elderly woman who presented with an acquired sideroblastic anemia is studied. Molecular analysis revealed that she was heterozygous for a missense mutation in the ALAS2 gene, but she expressed only the mutated gene in reticulocytes. Her 2 daughters and a granddaughter were heterozygous for this mutation, had normal hemoglobin levels, and expressed the normal ALAS2 gene in reticulocytes. A grandson with a previous diagnosis of thalassemia intermedia was found to be hemizygous for the ALAS2 mutation. Treatment with pyridoxine completely corrected the anemia both in the proband and her grandson. All women who were analyzed in this family showed skewed X-chromosome inactivation in leukocytes, which indicated a hereditary condition associated with unbalanced lyonization. Because the preferentially active X chromosome carried the mutant ALAS2 allele, acquired skewing in the elderly likely worsened the genetic condition and abolished the normal ALAS2 allele expression in the proband. (Blood. 2000;96:4363-4365)
|
| pubmed:grant | |
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0006-4971
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
96
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
4363-5
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:11110715-5-Aminolevulinate Synthetase,
pubmed-meshheading:11110715-Adolescent,
pubmed-meshheading:11110715-Adult,
pubmed-meshheading:11110715-Aged,
pubmed-meshheading:11110715-Alleles,
pubmed-meshheading:11110715-Anemia, Refractory,
pubmed-meshheading:11110715-Anemia, Sideroblastic,
pubmed-meshheading:11110715-Blood Transfusion,
pubmed-meshheading:11110715-Diagnosis, Differential,
pubmed-meshheading:11110715-Diagnostic Errors,
pubmed-meshheading:11110715-Dosage Compensation, Genetic,
pubmed-meshheading:11110715-Female,
pubmed-meshheading:11110715-Hematopoiesis,
pubmed-meshheading:11110715-Heterozygote,
pubmed-meshheading:11110715-Humans,
pubmed-meshheading:11110715-Leukocytes,
pubmed-meshheading:11110715-Male,
pubmed-meshheading:11110715-Middle Aged,
pubmed-meshheading:11110715-Pedigree,
pubmed-meshheading:11110715-Pyridoxine,
pubmed-meshheading:11110715-Thalassemia,
pubmed-meshheading:11110715-X Chromosome
|
| pubmed:year |
2000
|
| pubmed:articleTitle |
Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females.
|
| pubmed:affiliation |
Department of Hematology, University of Pavia Medical School, Italy. m.cazzola@iol.it
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Case Reports,
Research Support, Non-U.S. Gov't
|